Sopheon PLC
01 October 2007
Embargoed Release: 07:00hrs Monday 1 October 2007
Sopheon Plc
('Sopheon', the 'Group' or the 'Company')
Scott Bader Sharpens Innovation Focus
with Sopheon's Accolade(R) System
Sopheon, the international software and services company, announced today that
Scott Bader, a U.K.-based producer of composite and specialty polymer resins,
has selected Sopheon's Accolade product life cycle management (PLM) solution to
enhance the company's product innovation and portfolio management processes.
Scott Bader will deploy the Sopheon system among users in research and
development, marketing and executive roles at company locations in the U.K.,
France, North America, Croatia, South Africa and Dubai.
Founded in 1920, Scott Bader has a rich history as a product innovator. The
company created the first polyester resin that would cure at room temperature,
the first air-drying polyesters, and the first polyester resins for marine
applications. The latter were used to make the hull for the world's first large
glass-reinforced plastic boat. Scott Bader is a past winner of the Queens
Award, the highest honor a U.K. company can receive for technological
innovation.
Against this backdrop of achievement, Scott Bader recently launched an
organization-wide strategic initiative aimed at renewing the company's
commitment to innovation. A principal goal of the effort is to increase market
share by accelerating product development and bringing more successful products
to market. Underlying strategies include shifting the focus of research and
development away from custom resin solutions toward new-to-the-world products
with broad market appeal. Sopheon's Accolade system will play a central part in
the initiative by enabling Scott Bader to automate its product development
process and make more informed decisions about which product ideas to develop.
In addition to providing process automating capabilities, the Accolade modules
being deployed by Scott Bader will furnish advanced support for product
portfolio, resource and idea management. Expected advantages include more
effective prioritization of product development projects, improved visibility of
project details, stronger collaboration within project teams and across
functional silos, and more consistent focus of resources on commercially
promising product opportunities. The idea management module will facilitate the
submission and capture of product ideas and supply scorecards that will help
users systematically and objectively evaluate them. Scott Bader is also
implementing an Accolade Accelerator application that will reduce the amount of
time required to put the company's new innovation process in place.
'It's important to our business success that we continue to further the maturity
of our innovation process,' said Global Research and Development Director Roy
Phillipps of Scott Bader. 'One area where we want to grow in sophistication is
process measurement. Accolade will help us capture the metrics needed to track
and evaluate the efficiency and predictability of our process and the business
value of the projects that pass through it. The best-practice content provided
by the Sopheon system is also important to us because it will enhance our
reporting capabilities and support the kind of 'what-if' analysis
required to make the right go/kill business decisions on projects coming into
our developmental pipeline. Chemistry is our business. But innovation is our
path to creating value for our customers. We view Accolade as a critical
component of our value-creation strategy.'
'Today's chemical industry is $2.2 trillion in size and growing,' said Bryan
Seyfarth, solutions marketing director for Sopheon. 'For most chemical
producers, however, product commoditization is a significant, continuing
challenge. Scott Bader has long understood that the answer is product
innovation. They have made it a focal point of their business goals and
philosophy. The business decision-support and process efficiencies that
Accolade can provide are directly aligned with their requirements. Scott Bader
joins more than 50 top chemical and chemical-related companies around the world
that are using Accolade today to address their needs for effective innovation
process governance.'
Sopheon Accolade(R) is a registered trademark of Sopheon plc.
All other trademarks and registered trademarks are the sole property of their
respective owners.
About Scott Bader
Scott Bader is a global company which manufactures a wide range of UPR, DCPD and
VE resins, compounded resins, gelcoats, bonding pastes and structural adhesives
for the composite industry. Scott Bader is also a major European distributor of
reinforcements and ancillary products. Scott Bader Composites supplies high
quality, technically superior polyester resins and gelcoats under the Crystic(R)
brand name from manufacturing locations around the world. For more information,
please visit www.scottbader.com.
About Sopheon
Sopheon (LSE:SPE) is an international provider of software and services that
help organizations improve the business impact of product innovation. Sopheon's
solutions automate and govern the innovation process, enabling companies to
increase revenue and profits from new products. Sopheon is listed on the AIM
Market of the London Stock Exchange and on the Euronext in the Netherlands. For
more information, please visit www.sopheon.com.
For further information contact:
Barry Mence, Chairman Sopheon plc Tel : + 44 (0) 1483 685 735
Arif Karimjee, CFO
Andrew Tan Hansard Tel : + 44 (0) 207 245 1100
+ 44 (0) 7957 203 685
Floor van Maaren Citigate First Financial Tel : + 31 (0) 205 754 010
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.